Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
20 patents granted to the 6 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Harrow, Inc.’s names, not what it holds today.
Patents granted
20
20 utility, 1976 to Dec 31, 2025
Granted in 2025
2
Against 2 in 2024 and none in 2023
Applications published
66
1 of them in 2025
Names they are printed under
6
a former name, its holding company
By yearGrantedApplications published
'13'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals7
Audio-visual technology2
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name6 counted
IMPRIMIS PHARMACEUTICALS, INC. a former name
named as the applicant on its applications, in US
31 publishedHarrow IP, LLC its holding company
named as the applicant on its applications, in US; a holding company under the name HARROW, INC.
23 publishedHARROW IP, LLC its holding company
US, as the owner printed on each patent; a holding company under the name HARROW, INC.
2 publishedIMPRIMIS PHARMACEUTICALS, INC. a former name
US, as the owner printed on each patent
7 publishedHarrow Health, Inc. a former name
named as the applicant on its applications, in US
3 publishedHarrow Health, Inc. a former name
US, as the owner printed on each patent
0 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Nov 25, 2025 | 12,478,639 | Ocular lubricant formulations | Pharmaceuticals | HARROW IP, LLC |
| Oct 14, 2025 | 12,443,276 | Methods and system for remotely capturing media via a user interface bidirectionally linked to a remote server | Audio-visual technology | HARROW IP, LLC |
| Jul 23, 2024 | 12,045,386 | Methods and system for remotely capturing media via a user interface bidirectionally linked to a remote server | Audio-visual technology | HARROW IP, LLC |
| Mar 5, 2024 | 11,918,603 | Ocular lubricant formulations | Pharmaceuticals | HARROW IP, LLC |
| Dec 27, 2022 | 11,534,481 | Adrenocorticotropic hormone-based pharmaceutical formulations and methods for fabricating and using thereof | Pharmaceuticals | HARROW IP, LLC |
| May 24, 2022 | 11,338,018 | Adrenocorticotropic hormone-based pharmaceutical formulations and methods for fabricating and using thereof | Pharmaceuticals | HARROW IP, LLC |
| Nov 30, 2021 | 11,185,546 | Pharmaceutical formulations for the treatment of dry eye and methods for fabricating and using thereof | Pharmaceuticals | HARROW IP, LLC |
| Jun 29, 2021 | 11,045,432 | Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof | Pharmaceuticals | HARROW IP, LLC |
| May 4, 2021 | 10,993,921 | Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof | Pharmaceuticals | HARROW IP, LLC |
| Jun 30, 2020 | 10,695,351 | Pharmaceutical formulations for the treatment of dry eye and methods for fabricating and using thereof | Pharmaceuticals | HARROW IP, LLC |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Jun 12, 2025 | 2025/0186415 | EXTENDED-RELEASE PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE CONDITIONS | Pharmaceuticals | Harrow IP, LLC |
| Dec 26, 2024 | 2024/0423970 | EXTENDED-RELEASE PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE CONDITIONS | Pharmaceuticals | Harrow IP, LLC |
| Oct 10, 2024 | 2024/0338074 | METHODS AND SYSTEM FOR REMOTELY CAPTURING MEDIA VIA A USER INTERFACE BIDIRECTIONALLY LINKED TO A REMOTE SERVER | Audio-visual technology | HARROW IP, LLC · patent 12,443,276 granted from it |
| Jun 20, 2024 | 2024/0197773 | OCULAR LUBRICANT FORMULATIONS | Pharmaceuticals | Harrow IP, LLC · patent 12,478,639 granted from it |
| Feb 22, 2024 | 2024/0058320 | MYDRIATIC COMPOSITIONS AND METHODS FOR FABRICATING THEREOF | Pharmaceuticals | Harrow IP, LLC |
| Sep 28, 2023 | 2023/0302032 | ANTIBACTERIAL COMPOSITIONS AND METHODS FOR FABRICATING THEREOF | Pharmaceuticals | Harrow IP, LLC |
| Sep 7, 2023 | 2023/0277694 | OPHTHALMIC DYE COMPOSITION AND METHOD FOR ADMINISTERING SAME | Pharmaceuticals | Harrow IP, LLC |
| Sep 7, 2023 | 2023/0277521 | EXTENDED-RELEASE PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE CONDITIONS | Pharmaceuticals | Harrow IP, LLC |
| Jun 15, 2023 | 2023/0181630 | PACKAGED COMPOSITIONS COMPRISING HYPOCHLOROUS ACID AND MENTHOL AND METHODS OF MAKING THEREOF | Pharmaceuticals | Harrow IP, LLC |
| Jun 15, 2023 | 2023/0181625 | METHOD AND COMPOSITION FOR TREATING INFECTIOUS CONJUNCTIVITIS | Pharmaceuticals | Harrow IP, LLC |
What it applied for, 2024 to 2025: Pharmaceuticals 4 · Audio-visual technology 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.